China Pledges RMB 800 Million For Cataract Surgeries, Bringing Ophthalmic Market Potential Into Focus
This article was originally published in PharmAsia News
Executive Summary
With a large aging population, China’s ophthalmic market is poised to see growth, and companies with mixed product portfolios will be the biggest winners, analysts say.